FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1281-1282 October 25, 2001 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: We previously reported that in a multicenter, randomized trial that involved 105 patients with limited small-cell lung cancer, higher initial doses of cyclophosphamide and cisplatin improved overall survival.¹ The study was stopped early at the recommendation of an independent data-monitoring committee, and the median duration of follow-up at the time of publication was 33 months.² To evaluate whether these findings persisted over the long term, we reevaluated the patients after a median follow-up period of 11 years.

The updated overall survival rates for patients who received higher initial doses of cisplatin (100 mg per square meter of . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Pautier, P., Ribrag, V., Duvillard, P., Rey, A., Elghissassi, I., Sillet-Bach, I., Kerbrat, P., Mayer, F., Lesoin, A., Brun, B., Crouet, H., Barats, J. C., Morice, P., Lhomme, C. (2007). Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type. Ann Oncol 18: 1985-1989 [Abstract] [Full Text]  
• Abdollahi, A., Lipson, K. E., Sckell, A., Zieher, H., Klenke, F., Poerschke, D., Roth, A., Han, X., Krix, M., Bischof, M., Hahnfeldt, P., Grone, H.-J., Debus, J., Hlatky, L., Huber, P. E. (2003). Combined Therapy with Direct and Indirect Angiogenesis Inhibition Results in Enhanced Antiangiogenic and Antitumor Effects. Cancer Res. 63: 8890-8898 [Abstract] [Full Text]